Lyme Disease Treatment Market Driven by Growing Demand from North America, Asia Pacific| Size, Share, Demand and Key Player Analysis by 2026
Global Lyme Disease Treatment Market – Insights
Transmission of the bacterium – Borrelia burgdorferi through bites of infected adult black-legged ticks can cause Lyme disease. The transmission can take place if the tick is attached to the host body for 36 to 48 hours. The northeastern, mid-Atlantic, and north-central areas of the U.S. witness Lyme disease due to blacklegged ticks, whereas western black-legged ticks spread the disease in the regions along the Pacific Coast. Fever, headaches, swollen lymph nodes, chills, fatigue, muscle and joint aches, and characteristic skin rash (erythema migrans) are some of the early symptoms of Lyme disease. Avoiding treatment can lead to further discomfort such as intermittent pain in muscles, tendons, joints, and bones, coupled with severe headaches, neck stiffness, arthritis with severe joint pain, increased heart palpitations or an irregular heartbeat, nerve swelling in knees, facial palsy, pain, and inflammation of the brain and spinal cord. According to the Centers for Disease Control and Prevention (CDC), erythema migrans affects around 70% to 80% of infected people, worldwide.
For more Information, Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-sample/862
Lyme carditis is a rare complication in Lyme disease and is a result of the infection invading the heart tissue. The condition can lead to mild, moderate, or severe heart blockage and palpitations, lightheadedness, blackouts, chest pain, and dyspnea. According to the National Surveillance Data, by National Notifiable Disease Surveillance System (NNDSS), between 2001 and 2010, Lyme carditis affected around 1% of patients suffering from Lyme disease, in the U.S. Intravenous or oral antibiotics, preferably ceftriaxone are used for the treatment of Lyme carditis. However, depending upon the severity of infection, some patients might require implantation of a temporary or permanent pacemaker.
Antibiotics such as doxycycline, amoxicillin, and cefuroxime axetil are a potential therapy in the treatment of Lyme disease and are effective in early stages of the disease. Moreover, intravenous ceftriaxone can also be used in the treatment of patients with certain neurological or cardiac disorder. Oral antibiotic treatment proves effective in the treatment of patients with chronic symptoms of Lyme disease and the recovery period is a few weeks or over 6 months. According to International Lyme and Associated Disease Society (ILADS), it is challenging to diagnose and treat Lyme disease and it may result in persistent infection. Although no single antibiotic or combination of antibiotics has demonstrated the ability to eliminate Lyme disease infection, ILADS recommends individualized treatment based on the severity of symptoms, tick-borne coinfections, and patient’s response to treatment. Therefore, increasing demand for potent antibiotic for the treatment of Lyme disease and the prevailing cases of the disease is expected to propel growth of the global Lyme disease treatment market over the forecast period.
Quick Buy – Lyme Disease Treatment Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/862
R&D of new vaccines is expected to boost growth of the global Lyme disease treatment market. For instance, in July 2017, the U.S. Food and Drug Administration (FDA) granted fast track designation to the first vaccine for Lyme disease – VLA15, created by Valneva SE – a Europe-based biotech firm. The company plans to initiate the phase 2 studies in early 2018.
However, increasing consumption of antibiotics can eliminate beneficial intestinal flora, which may have adverse health effects, which is expected to hinder growth of the global Lyme disease treatment market.
Global Lyme Disease Treatment Market Taxonomy:
By disease type:
- Early Lyme disease (absence of erythema migrans)
- Lyme carditis
- Lyme arthritis
- neurologic Lyme disease
- Borrelial lymphocytosis
- Post-treatment Lyme Disease Syndrome (PTLDS)
- Cefuroxime axetil
- Others (azithromycin, clarithromycin, erythromycin)
- North America
- Latin America
- Asia Pacific
- Middle East
Got any Query? Feel free to ask us at : https://www.coherentmarketinsights.com/insight/talk-to-analyst/862
Global Lyme Disease Treatment Market: Regional Analysis
North America is expected to hold dominant position in the global Lyme disease market over the forecast period. This is attributed to high prevalence of Lyme disease in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), around 28,453 confirmed cases of Lyme disease and 9 new cases per 1,00,000 people were recorded in the U.S. during the 2005 – 2015.
Increasing prevalence of Lyme disease is expected to boost growth of the market in Europe. For instance, according to the 2014 factsheet of European Centers for Disease Control and Prevention (ECDC), prevalence of Lyme disease is steadily increasing in Europe.
Global Lyme Disease Treatment Market: Competitive Landscape
Key players operating in the global Lyme disease treatment market include, Lupin Ltd., Mylan N.V., Sun Pharmaceuticals Industries Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., G&W Laboratories, Inc., Sandoz AG, GlaxoSmithKline plc., and Hospira Inc.
Table of Content
Global Lyme Disease Treatment Market Research Report
Section 1: Global Lyme Disease Treatment Industry Overview
Section 2: Global Economic Impact on Lyme Disease Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Lyme Disease Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Lyme Disease Treatment Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire